RESEARCH-USE BIOSIMILAR ANTIBODY
Divozilimab
Monoclonal antibody · IgG1
Divozilimab (BCD-132) is a humanised monoclonal antibody against CD20 (CD20). Divozilimab can be used for multiple sclerosis research.
TARGETMS4A1
YMonoclonal antibody
CATALOGSC-BS-627
CATALOG NUMBERSC-BS-627
MOLECULAR WEIGHTApprox. 145.26 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Divozilimab (BCD-132) is a humanised monoclonal antibody against CD20 (CD20). Divozilimab can be used for multiple sclerosis research.
Divozilimab is a recombinant research-use antibody directed against MS4A1.